Table 3.
AXL immunohistochemical expression compared with clinicopathologic variables for patients with luminal B tumours
| Characteristic (n=203) | Number | Axl H-Score median (min, max) | p Value |
|---|---|---|---|
| Age (mean years±SD) | 58±13 | ||
| Stage | 0.427 | ||
| I | 117 | 15 (0, 300) | |
| II | 68 | 15 (0, 300) | |
| III | 18 | 10 (0, 80) | |
| Tumour size | 0.745 | ||
| T1 | 142 | 17.5 (0, 300) | |
| T2 | 55 | 10 (0, 300) | |
| T3 | 6 | 10 (0, 20) | |
| Node status | 0.652 | ||
| N0 | 143 | 15 (0, 300) | |
| N1 | 45 | 30 (0, 300) | |
| N2 | 12 | 10 (0, 80) | |
| N3 | 3 | 40 (0, 80) | |
| Histologic grade | 0.523 | ||
| 1 | 7 | 10 (0, 200) | |
| 2 | 69 | 15 (0, 300) | |
| 3 | 107 | 15 (0, 300) | |
| ILC | 20 | 10 (0, 300) | |
| Lymphovascular invasion | 0.981 | ||
| Present | 45 | 20 (0, 270) | |
| Absent | 158 | 10 (0, 300) |
ILC, invasive lobular carcinoma.